We are live on
!
Find out more
EEG
E.E. Geduld Portfolio holdings
AUM
$178M
1-Year Est. Return
29.34%
This Fund
S&P 500
This Quarter
Est. Return
-7.61%
1 Year Est. Return
+29.34%
3 Year Est. Return
+59.91%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$107M
AUM Growth
-$54.2M
(-34%)
Cap. Flow
-$24M
Cap. Flow
% of AUM
-22.49%
Top 10 Holdings %
Top 10 Hldgs %
54.93%
Holding
347
New
45
Increased
19
Reduced
60
Closed
132
Avg Time Held Equity + Options
4.4
quarters
Top 10 Avg Time Held Equity + Options
2.2
quarters
Top 20 Avg Time Held Equity + Options
2.4
quarters
Avg Time Held Equity only
4.6
quarters
Top 10 Avg Time Held Equity only
3.6
quarters
Top 20 Avg Time Held Equity only
3.2
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.59M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$1.36M |
| 3 |
Silicon Motion
SIMO
|
+$870K |
| 4 |
Amazon
AMZN
|
+$758K |
| 5 |
LNKD
LinkedIn Corporation
LNKD
|
+$596K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
bluebird bio
BLUE
|
+$1.75M |
| 2 |
CSOD
Cornerstone OnDemand, Inc.
CSOD
|
+$957K |
| 3 |
Capri Holdings
CPRI
|
+$842K |
| 4 |
Sage Therapeutics
SAGE
|
+$803K |
| 5 |
CY
Cypress Semiconductor
CY
|
+$764K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 45.84% |
| 2 | Miscellaneous | 25.05% |
| 3 | Healthcare | 9.93% |
| 4 | Consumer Discretionary | 6.85% |
| 5 | Technology | 4.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
OTE
126
DELISTED
HELLENIC TELECOMM ORG ADS(RP1/
OTE
| $54K | 0.05% |
12,500
| – | – |
2013 Q2
9 quarters
|
|
127
Fate Therapeutics
FATE
$255M
| $53K | 0.05% |
10,000
-27,000
| -73% | -$184K |
2015 Q2
1 quarter
|
|
128
Fortress Biotech
FBIO
$70.4M
| $52K | 0.05% |
1,333
-334
| -20% | -$15.6K |
2013 Q2
9 quarters
|
|
129
DELISTED
Bank Of America Corporation Ws B
BAC.WS.B
| $49K | 0.05% |
175,000
| – | – |
2013 Q2
9 quarters
|
|
|
CGRN
130
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
| $43K | 0.04% |
625
+125
| +25% | +$9.15K |
2013 Q2
9 quarters
|
|
131
DELISTED
Associated Banc-Corp Warrants
ASB.WS
| $41K | 0.04% |
18,300
-100
| -0.5% | -$281 |
2013 Q2
9 quarters
|
|
|
IMNP
132
DELISTED
Immune Pharmaceuticals Inc.
IMNP
| $41K | 0.04% |
1,750
| – | – |
2014 Q3
4 quarters
|
|
|
ECTE
133
DELISTED
ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE)
ECTE
| $39K | 0.04% |
25,000
| – | – |
2013 Q2
9 quarters
|
|
134
Rigel Pharmaceuticals
RIGL
$912M
| $37K | 0.03% |
1,500
-1,000
| -40% | -$29.8K |
2015 Q1
2 quarters
|
|
135
Hovnanian Enterprises
HOV
$617M
| $35K | 0.03% |
800
-200
| -20% | -$9.83K |
2015 Q1
2 quarters
|
|
136
Aware
AWRE
$21.8M
| $34K | 0.03% |
10,000
| – | – |
2013 Q4
7 quarters
|
|
|
TCF.WS
137
DELISTED
TCF Financial Corporation
TCF.WS
| $32K | 0.03% |
15,100
| – | – |
2013 Q2
9 quarters
|
|
138
DELISTED
Cel-Sci Corp Series S
CVM.WS
| $28K | 0.03% |
100,000
| – | – |
2014 Q2
5 quarters
|
|
|
XCO
139
DELISTED
Exco Resources
XCO
| $27K | 0.03% |
2,400
+733
| +44% | +$8.09K |
2013 Q2
9 quarters
|
|
|
PLM
140
DELISTED
PolyMet Mining Corp.
PLM
| $27K | 0.03% |
4,000
+250
| +7% | +$2.3K |
2013 Q2
9 quarters
|
|
|
GCVRZ
141
DELISTED
Sanofi Contingent Value Rights
GCVRZ
| $24K | 0.02% |
125,000
-25,000
| -17% | -$8.5K |
2013 Q2
9 quarters
|
|
|
RNDY
142
DELISTED
ROUNDYS INC COM STK
RNDY
| $23K | 0.02% |
10,000
-10,000
| -50% | -$26.5K |
2014 Q4
3 quarters
|
|
143
DELISTED
Kinder Morgan Inc
KMI.WS
| $23K | 0.02% |
25,000
-75,000
| -75% | -$115K |
2014 Q1
6 quarters
|
|
|
BBEP
144
DELISTED
BREITBURN ENERGY PARTNERS LP COM UNITS RPTNG LTD PRTNRSHIP
BBEP
| $20K | 0.02% |
10,000
-15,000
| -60% | -$44.6K |
2015 Q2
1 quarter
|
|
|
NBG
145
DELISTED
NATIONAL BANK OF GREECE SA ADR REPSTG 1 SHARE (NEW)
NBG
| $16K | 0.02% |
35,000
| – | – |
2015 Q1
2 quarters
|
|
|
EMIS
146
DELISTED
EMISPHERE TECHNOLOGIES INC
EMIS
| $14K | 0.01% |
25,000
| – | – |
2013 Q2
9 quarters
|
|
147
DELISTED
Citigroup Inc
C.WS.A
| $12K | 0.01% |
25,000
| – | – |
2013 Q2
9 quarters
|
|
148
DELISTED
AMERICAN APPAREL INC COM
APP
| $11K | 0.01% |
100,000
-50,000
| -33% | -$11.2K |
2013 Q2
9 quarters
|
|
|
SFXE
149
DELISTED
SFX ENTERTAINMENT, INC COM
SFXE
| $8K | 0.01% |
15,000
| – | – |
2014 Q4
3 quarters
|
|
|
OPXAW
150
DELISTED
Opexa Therapeutics, Inc.
OPXAW
| $7K | 0.01% |
+60,200
| New | +$7.31K |
2015 Q3
0 quarters
|
|
Similar funds
BC
PFM
SRP
CF
SA
WSA
SIG
VWM
E.E. Geduld's Q3 2015 Portfolio in Review
As of Q3 2015, E.E. Geduld held 347 positions worth $107M, down 34% from $161M the previous quarter. Its ten largest holdings account for 55% of the portfolio.
E.E. Geduld withdrew a net $24M in Q3 2015, closing 132 positions and reducing 60 holdings. Its most notable exit was bluebird bio, an estimated $1.75M position sold in full.
By sector, the portfolio is most concentrated in Financials at 46% of assets, up from 33% a quarter earlier, followed by Miscellaneous and Healthcare.
Against the trend, E.E. Geduld opened a new position in Bristol-Myers Squibb worth $1.48M.
- E.E. Geduld's largest Q3 2015 buy was Bristol-Myers Squibb: 25,000 shares worth $1.48M.
- E.E. Geduld added most to Amazon in Q3 2015, an estimated $758K increase.
- E.E. Geduld's biggest Q3 2015 reduction was Ariad Pharmaceuticals Inc, cutting an estimated $578K.
- E.E. Geduld fully exited bluebird bio in Q3 2015, selling an estimated $1.75M.
- E.E. Geduld's ten largest holdings make up 55% of its $107M portfolio in Q3 2015.
- E.E. Geduld opened 45 new positions and closed 132 in Q3 2015.
- E.E. Geduld's portfolio value fell 34% quarter-over-quarter to $107M.
Based on E.E. Geduld's 13F filing for Q3 2015, filed 6 Nov 2015.